IBDEI15C ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20533,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,20533,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,20534,0)
 ;;=V12.54^^131^1289^56
 ;;^UTILITY(U,$J,358.3,20534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20534,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,20534,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,20534,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,20535,0)
 ;;=V12.54^^131^1289^52
 ;;^UTILITY(U,$J,358.3,20535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20535,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,20535,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,20535,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,20536,0)
 ;;=V15.88^^131^1289^33
 ;;^UTILITY(U,$J,358.3,20536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20536,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,20536,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,20536,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,20537,0)
 ;;=V13.59^^131^1289^42
 ;;^UTILITY(U,$J,358.3,20537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20537,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,20537,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,20537,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,20538,0)
 ;;=V15.52^^131^1289^55
 ;;^UTILITY(U,$J,358.3,20538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20538,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,20538,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,20538,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,20539,0)
 ;;=V12.04^^131^1289^38
 ;;^UTILITY(U,$J,358.3,20539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20539,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,20539,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,20539,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,20540,0)
 ;;=V13.51^^131^1289^23
 ;;^UTILITY(U,$J,358.3,20540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20540,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,20540,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,20540,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,20541,0)
 ;;=V15.51^^131^1289^58
 ;;^UTILITY(U,$J,358.3,20541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20541,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,20541,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,20541,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,20542,0)
 ;;=V62.22^^131^1289^49
 ;;^UTILITY(U,$J,358.3,20542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20542,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,20542,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,20542,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,20543,0)
 ;;=V70.0^^131^1290^1
 ;;^UTILITY(U,$J,358.3,20543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20543,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,20543,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,20543,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,20544,0)
 ;;=V77.91^^131^1290^2
 ;;^UTILITY(U,$J,358.3,20544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20544,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,20544,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,20544,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,20545,0)
 ;;=V76.44^^131^1290^3
 ;;^UTILITY(U,$J,358.3,20545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20545,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,20545,1,5,0)
 ;;=5^Screen for Prostate CA
 ;;^UTILITY(U,$J,358.3,20545,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,20546,0)
 ;;=V74.5^^131^1290^5
 ;;^UTILITY(U,$J,358.3,20546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20546,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,20546,1,5,0)
 ;;=5^Screening for STD's
 ;;^UTILITY(U,$J,358.3,20546,2)
 ;;=Screening for STD's^295637
